MULTI-HEARTSNCT07536919
Implementation Support for HEARTS-Based Hypertension and Diabetes Care in Guatemala
StatusNot Yet Recruiting
PhaseNot applicable
SponsorUniversity of Michigan
Primary completion (estimated)
At risk: Primary completion moved at least 4 months later, primary endpoint(s) modified.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
Notable Start date: May 1, 2027 to Oct 2027 Show 9 more changesShow less
- Primary endpoint(s) modified
- Eligibility criteria expanded, about 106 words
- Primary and study completion pushed from May 1, 2030 to Sep 2030
- Interventions modified
- Study sites: 0 to 1
- Secondary endpoints: 4 to 5
- Study description expanded, about 119 words
- Collaborators expanded, about 36 words
- Study title revised
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Systolic blood pressure
Timeframe: 12 months after the enrollment visit
Secondary (5)
Hemoglobin A1c
Diastolic blood pressure
Proportion of participants with blood pressure control
Proportion of participants with hemoglobin A1c control
Proportion of participants with combined blood pressure control and hemoglobin A1c control
Arms and interventions
Implementation support armExperimental
Routine HEARTS implementation with additional implementation support from INCAP for 36 months.
Routine implementation armActive comparator
Routine HEARTS implementation alone.
Other: HEARTS implementation support, Routine HEARTS implementation
Sites
1 site in 1 country
- Ministry of Health health centersGuatemala City, Guatemala